A carregar...
Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab
A 65‐year‐old man with chronic progressive pulmonary aspergillosis (CPPA) was admitted for the treatment of lung adenocarcinoma while receiving an immune checkpoint inhibitor, nivolumab. The tumour responded well to the therapy, but the cavity of CPPA became large in contrast to the tumour after 20...
Na minha lista:
| Publicado no: | Respirol Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756713/ https://ncbi.nlm.nih.gov/pubmed/29321933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.289 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|